| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.83B | +34.6% |
| Cost of Revenue | $2.01B | +38.7% |
| Gross Profit | $1.81B | +30.4% |
| R&D Expense | $1.08B | +36.7% |
| SG&A Expense | $517.4M | +9.5% |
| Operating Income | -$1.21B | -31.6% |
| Pre-tax Income | -$1.24B | -29.4% |
| Income Tax | $12.5M | +213.5% |
| Net Income | -$1.26B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $651.8M | -55.9% |
| Accounts Receivable | $547.5M | +41.0% |
| Current Assets | $4.98B | -16.0% |
| Total Assets | $12.56B | -3.3% |
| Current Liabilities | $808.2M | +14.9% |
| Long-term Debt | $987.4M | +0.1% |
| Total Liabilities | $2.01B | +1.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$254.4M | -337.1% |
| Investing Cash Flow | -$616.5M | +75.2% |
| Financing Cash Flow | $45.0M | -98.5% |
| -32.2% |
| EPS (Basic) | -$6.86 | -25.9% |
| EPS (Diluted) | -$6.86 | -25.9% |
| Stockholders' Equity |
| $10.56B |
| -4.3% |